The Business Research Company’s Diuretics Global Market Report 2021 – COVID-19 Impact and Recovery
LONDON, GREATER LONDON, UK, September 17, 2021 /EINPresswire.com/ — An increase in renal and kidney disorder cases drives the diuretics drug market. In such cases, the kidney does not function properly increase the need for water-pills (diuretic drugs) to maintain a proper flow of urine. The rise in kidney disorders can be attributed to change in lifestyle such as consumption of unhealthy food high in calcium and other minerals. For example, according to the National Kidney Foundation Inc, in 2019, about 1 out of every 7 or 15% of the adult population in America have chronic kidney disease (CKD).
The global diuretics market size is expected to grow from $0.82 billion in 2020 to $0.91 billion in 2021 at a compound annual growth rate (CAGR) of 11%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The diuretics market is expected to reach $1.18 billion in 2025 at a CAGR of 6.7%.
Read More On The Global Diuretics Market Report:
Major players covered in the global diuretics market are Merck & Co., Meda Manufacturing GmbH, Pfizer Inc., Glaxosmithkline, and Roche.
TBRC’s global diuretics market report is segmented by type into osmotic diuretics, carbonic anhydrase inhibitors, loop diuretics, thiazides & thiazide-like diuretics, aldosterone antagonists, by application into hypertension, glaucoma, heart failure, kidney stones, by distribution into hospital pharmacies, independent pharmacies, retail pharmacies, drug stores, online pharmacies, by route of administration into intravenous, oral.
A new drug delivery technology called the oral nanoparticle delivery technology has been developed to improve the pH and intestinal permeability of the diuretic drugs to increase the digesting capability as a majority of these drugs have low water solubility and bioavailability. Drugs such as amlodipine and isradipine having low bioavailability (a smaller number of solvents to get diluted) and high light sensitivity were delivered using nano emulsion (dispersion that consist of oil, surfactants and aqueous phase) as a drug delivery system. Pharmacokinetics data of both the drugs revealed enhanced stability and bioavailability. Nanomerics, a pharmaceutical nanotechnology drug delivery company, is carrying out R&D in this technology by working on MET (Molecule Envelop Technology) Nanoparticles Oral Delivery. Also, in 2020, a Japanese research team from Kumamoto University developed a new nanocarrier drug delivery technology to enhance the drugs, by moving from the blood into the brain.
Diuretics Global Market Report 2021 – By Type (Osmotic Diuretics, Carbonic Anhydrase Inhibitors, Loop Diuretics, Thiazides & Thiazide-Like Diuretics, Aldosterone Antagonists), By Application (Hypertension, Glaucoma, Heart Failure, Kidney Stones), By Distribution Channel (Hospital Pharmacies, Independent Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies), By Route of Administration (Intravenous, Oral), COVID-19 Impact and Recovery is one of a series of new reports from The Business Research Company that provides diuretics market overview, forecast diuretics market size and growth for the whole market, diuretics market segments, and geographies, diuretics market trends, diuretics market drivers, restraints, leading competitors’ revenues, profiles, and market shares.
Request For A Sample Of The Global Diuretics Market Report:
Here Is A List Of Similar Reports By The Business Research Company:
Pharmaceutical Drugs Market – By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
Anti-Hypertensive Drugs Global Market Report 2021 – By Therapeutics (Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators), By Disease Source (Primary Hypertension, Secondary Hypertension), By End Users (Hospitals, Clinics, Homecare), COVID-19 Impact And Recovery
Genito-Urinary Drugs Global Market Report 2021 – By Type (Hormonal Contraceptives, Drugs For Benign Prostatic hypertrophy, Drugs For Infertility, Drugs For Erectile Dysfunction, Drugs For Urinary Incontinence And Overactive Bladder, Drugs For Infections And Others, Drugs For Hormonal Replacement Therapy, Diuretics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), COVID-19 Impact And Recovery
Interested to know more about The Business Research Company?
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
Or get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Source: EIN Presswire